Regulation of immunoproteasome function in the lung

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Keller, Ilona E ^a   Vosyka, Oliver ^a,b   Takenaka, Shinji ^a   Kloß, Alexander ^c   Dahlmann, Burkhardt ^c   Willems, Lianne I ^d   Verdoes, Martijn ^d,i   Overkleeft, Hermen S ^d   Marcos, Elisabeth ^e   Adnot, Serge ^e   Hauck, Stefanie M ^b   Ruppert, Clemens ^f   Günther, Andreas ^f,g   Herold, Susanne ^h   Ohno, Shinji ^b,j   Adler, Heiko ^b   Eickelberg, Oliver ^a   Meiners, Silke ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d LEIDEN UNIVERSITY   (Netherlands)

^e UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^f JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^g Agaplesion Pneumologische Klinik Waldhof Elgershausen   (Germany)

^h JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; GAMMA INTERFERON; LMP-2 PROTEIN; LMP7 PROTEIN; PROTEASOME;

ADAPTIVE IMMUNITY; ANIMAL; C57BL MOUSE; CELL LINE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETICS; HERPES VIRUS INFECTION; HUMAN; IMMUNOLOGY; LUNG; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MOUSE; RHADINOVIRUS; VIROLOGY; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; CELL LINE; CYSTEINE ENDOPEPTIDASES; FEMALE; HERPESVIRIDAE INFECTIONS; HUMANS; INTERFERON-GAMMA; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; PROTEASOME ENDOPEPTIDASE COMPLEX; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHADINOVIRUS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR VIRUS INFECTIONS;

EID: 84930221732     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10230     Document Type: Article

References (53)

1. Bals, R. & Hiemstra, P. S. Innate immunity in the lung: how epithelial cells fght against respiratory pathogens. Eur. Respir. J. 23, 327-333 (2004).
2. Brusselle, G. G., Joos, G. F. & Bracke, K. R. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378, 1015-1026 (2011).
3. Barnes, P. J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8, 183-192 (2008).
4. Goldberg, A. L. Protein degradation and protection against misfolded or damaged proteins. Nature 426, 895-899 (2003).
5. Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477-513 (2009).
6. Schmidt, M. & Finley, D. Regulation of proteasome activity in health and disease. Biochim. Biophys. Acta. 1843, 13-25 (2014).
7. Meiners, S., Keller, I. E., Semren, N. & Caniard, A. Regulation of the proteasome: evaluating the lung proteasome as a new therapeutic target. Antioxid. Redox Signal. 21, 2364-2382 (2014).
8. Aki, M. et al. Interferon-gamma induces diferent subunit organizations and functional diversity of proteasomes. J. Biochem. 115, 257-269 (1994).
9. Groettrup, M., Kirk, C. J. & Basler, M. Proteasomes in immune cells: more than peptide producers? Nat. Rev. Immunol. 10, 73-78 (2010).
10. Van Rijt, S. H. et al. Acute cigarette smoke exposure impairs proteasome function in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 303, L814-823 (2012).
11. Somborac-Bacura, A. et al. Cigarette smoke induces endoplasmic reticulum stress response and proteasomal dysfunction in human alveolar epithelial cells. Exp. Physiol. 98, 316-325 (2013).
12. Malhotra, D. et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am. J. Respir. Crit. Care Med. 180, 1196-1207 (2009).
13. Min, T., Bodas, M., Mazur, S. & Vij, N. Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema. J. Mol. Med. 89, 577-593 (2011).
14. Shin, E.-C. et al. Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J. Clin. Invest. 116, 3006-3014 (2006).
15. Yao, Y. et al. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens. Cell Res. 22, 836-847 (2012).
16. Murata, S., Yashiroda, H. & Tanaka, K. Molecular mechanisms of proteasome assembly. Nat. Rev. Mol. Cell Biol. 10, 104-115 (2009).
17. Verdoes, M. et al. A Fluorescent Broad-Spectrum Proteasome Inhibitor for Labeling Proteasomes In Vi t ro and In Viv o. Chem. Biol. 13, 1217-1226 (2006).
18. Li, N. et al. Relative quantifcation of proteasome activity by activity-based protein profling and LC-MS/MS. Nat. Protoc. 8, 1155-1168 (2013).
19. Noda, C., Tanahashi, N., Shimbara, N., Hendil, K. B. & Tanaka, K. Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. Biochem. Biophys. Res. Comm.un. 277, 348-354 (2000).
20. Kremer, M. et al. Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice. J. Immunol. 185, 5549-5560 (2010).
21. Gohlke, S. et al. Adult human liver contains intermediate-type proteasomes with diferent enzymatic properties. Ann Hepatol. 13, 429-438 (2014).
22. Ebstein, F., Kloetzel, P.-M., Krüger, E. & Seifert, U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell. Mol. Life Sci. 69, 2543-2558 (2012).
23. Baker, T. A., Bach, H. H., Gamelli, R. L., Love, R. B. & Majetschak, M. Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases. Physiol. Res. 63, 311-319 (2014).
24. Sixt, S. U. et al. Alveolar and intraparenchymal proteasome in sarcoidosis. Respir. Med. 108, 1534-1541 (2014).
25. Grifn, T. A. Immunoproteasome Assembly: Cooperative Incorporation of Interferon gamma (IFN-gamma)-inducible Subunits. J. Exp. Med. 187, 97-104 (1998).
26. Kingsbury, D. J., Grifn, T. A. & Colbert, R. A. Novel propeptide function in 20 S proteasome assembly infuences beta subunit composition. J. Biol. Chem. 275, 24156-24162 (2000).
27. Joeris, T. et al. The Proteasome System in Infection: Impact of β 5 and LMP7 on Composition, Maturation and Quantity of Active Proteasome Complexes. PLoS ONE 7, e39827; DOI:10.1371/journal.pone.0039827 (2012).
28. Simas, J. P. & Efstathiou, S. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol. 6, 276-282 (1998).
29. Mora, A. L. et al. Lung infection with gamma-herpesvirus induces progressive pulmonary fbrosis in T2-biased mice. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L711-721 (2005).
30. Basler, M., Kirk, C. J. & Groettrup, M. The immunoproteasome in antigen processing and other immunological functions. Curr. Opin. Immunol. 25, 74-80 (2013).
31. Hutchinson, S. et al. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS ONE 6, e14646; DOI:10.1371/journal.pone.0014646 (2011).
32. Kincaid, E. Z. et al. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat. Immunol. 13, 129-135 (2012).
33. Basler, M., Beck, U., Kirk, C. J. & Groettrup, M. The antiviral immune response in mice devoid of immunoproteasome activity. J. Immunol. 187, 5548-5557 (2011).
34. Morel, S. et al. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12, 107-117 (2000).
35. Opitz, E. et al. Impairment of Immunoproteasome Function by β 5i/LMP7 Subunit Defciency Results in Severe Enterovirus Myocarditis. PLoS Pathog. 7, e1002233; DOI:10.1371/journal.ppat.1002233 (2011).
36. Stewart, J. P., Usherwood, E. J., Ross, A., Dyson, H. & Nash, T. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187, 1941-1951 (1998).
37. Flaño, E., Husain, S. M., Sample, J. T., Woodland, D. L. & Blackman, M. A. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165, 1074-1081 (2000).
38. Mallia, P. et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am. J. Respir. Crit. Care Med. 183, 734-742 (2011).
39. Van Zyl-Smit, R. N. et al. Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages. Torax 69, 363-370 (2014).
40. Lugade, A. A. et al. Cigarette smoke exposure exacerbates lung infammation and compromises immunity to bacterial infection. J. Immunol. 192, 5226-5235 (2014).
41. Stämpfi, M. R. & Anderson, G. P. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat. Rev. Immunol. 9, 377-384 (2009).
42. Modestou, M. A., Manzel, L. J., El-Mahdy, S. & Look, D. C. Inhibition of IFN-gamma-dependent antiviral airway epithelial defense by cigarette smoke. Respir. Res. 11, 64 (2010).
43. Eddleston, J., Lee, R. U., Doerner, A. M., Herschbach, J. & Zuraw, B. L. Cigarette smoke decreases innate responses of epithelial cells to rhinovirus infection. Am. J. Respir. Cell Mol. Biol. 44, 118-126 (2011).
44. Robbins, C. S., Franco, F., Mouded, M., Cernadas, M. & Shapiro, S. D. Cigarette smoke exposure impairs dendritic cell maturation and T cell proliferation in thoracic lymph nodes of mice. J. Immunol. 180, 6623-6628 (2008).
45. Fujino, N. et al. Gene expression profles of alveolar type II cells of chronic obstructive pulmonary disease: a case-control study. BMJ Open 2, e001553; DOI:10.1136/bmjopen-2012-001553 (2012).
46. Sixt, S. U. et al. Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome. Mediators Infamm. 2012, 204250 (2012).
47. Expression of concern: decline in NRF2-regulated antioxidants in COPD lungs due to loss of its positive regulator, and heightened endoplasmic reticulum stress in the lungs of patients with COPD. Am. J. Respir. Crit. Care Med. 190, 1200 (2014).
48. Amsellem, V. et al. Telomere dysfunction causes sustained infammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 184, 1358-1366 (2011).
49. Korfei, M. et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fbrosis. Am. J. Respir. Crit. Care Med. 178, 838-846 (2008).
50. Van Kaer, L. et al. Altered peptidase and viral-specifc T cell response in LMP2 mutant mice. Immunity 1, 533-541 (1994).
51. Fehling, H. et al. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237 (1994).
52. Guggemoos, S. et al. TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J. Immunol. 180, 438-443 (2008).
53. Cravatt, B. F., Wright, A. T. & Kozarich, J. W. Activity-based protein profling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 77, 383-414 (2008).